Recent research published in the journal ‘Cancer’ suggests that aspirin may have a role in both preventing and treating colorectal cancer. The study found that colorectal cancer patients who took aspirin had less spread of the disease to their lymph nodes compared to those who did not take the drug. Aspirin appeared to boost the body's immune system, aiding in the tracking down of cancer cells. This promising finding adds to the growing body of evidence suggesting that aspirin could be more than just a pain reliever or a heart attack preventative.
Aspirin's potential role in cancer prevention
